Innate Pharma: Medical Director to Lead BTIG Panel on Bladder Cancer
The Marseille-based biotechnology group announced its participation in a leading virtual conference organized by BTIG on July 28, 2026. Sonia Quaratino, the laboratory's medical director, will lead a panel dedicated to the evolution of bladder cancer treatment.
Innate Pharma has been invited to participate in the discussion panel titled 'Changing Treatment Landscape in Bladder Cancer' during the BTIG Virtual Biotechnology Conference. This intervention will take place on July 28, 2026, at 10:30 AM EDT (4:30 PM CEST). Sonia Quaratino, serving as the medical director, will represent the group to discuss therapeutic evolution in this oncological indication.
This participation is part of the context of Innate Pharma's developments in immuno-oncology. The group is involved in several clinical phase programs, including IPH4502, a drug-conjugated antibody targeting Nectin-4, for which dose escalation recruitment was completed on July 21, 2026, with preliminary results expected by the end of the year.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Related
SectorIndustrie Pharmaceutique et Biotechnologie›Biotechnologie
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
